value_set_name,code_system,logical_definition,code,code_description,concept_id,concept_name,domain_id,vocabulary_id,concept_class_id,standard_concept,concept_code,valid_start_date,valid_end_date,invalid_reason
TumorMarkerTestVS,LOINC,NA,1695-6,5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine,3005148,5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine,Measurement,LOINC,Lab Test,S,1695-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,31203-3,5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine,3023028,5-Hydroxyindoleacetate [Mass/volume] in 24 hour Urine,Measurement,LOINC,Lab Test,S,31203-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1692-3,5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid,3014670,5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,1692-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1693-1,5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma,3021106,5-Hydroxyindoleacetate [Mass/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,1693-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1694-9,5-Hydroxyindoleacetate [Mass/volume] in Urine,3021385,5-Hydroxyindoleacetate [Mass/volume] in Urine,Measurement,LOINC,Lab Test,S,1694-9,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,72820-4,5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method,43055680,5-Hydroxyindoleacetate [Mass/volume] in Urine by Confirmatory method,Measurement,LOINC,Lab Test,S,72820-4,2012-12-10,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,14573-0,5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine,3009461,5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine,Measurement,LOINC,Lab Test,S,14573-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,25971-3,5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine,3010801,5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine,Measurement,LOINC,Lab Test,S,25971-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,47544-2,5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid,3051403,5-Hydroxyindoleacetate [Moles/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,47544-2,2006-12-11,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,74769-1,5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma,44816667,5-Hydroxyindoleacetate [Moles/volume] in Platelet rich plasma,Measurement,LOINC,Lab Test,S,74769-1,2014-03-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50149-4,5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma,3030136,5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,50149-4,2007-09-06,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,15009-4,5-Hydroxyindoleacetate [Moles/volume] in Urine,3036309,5-Hydroxyindoleacetate [Moles/volume] in Urine,Measurement,LOINC,Lab Test,S,15009-4,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,12172-3,5-Hydroxyindoleacetate [Presence] in 24 hour Urine,3036168,5-Hydroxyindoleacetate [Presence] in 24 hour Urine,Measurement,LOINC,Lab Test,S,12172-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,48168-9,5-Hydroxyindoleacetate [Presence] in Urine,3052387,5-Hydroxyindoleacetate [Presence] in Urine,Measurement,LOINC,Lab Test,S,48168-9,2007-01-16,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,11145-0,5-Hydroxyindoleacetate/â€‹Creatinine [Mass Ratio] in Urine,3012601,5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine,Measurement,LOINC,Lab Test,S,11145-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,44909-0,5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine,3047303,5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine,Measurement,LOINC,Lab Test,S,44909-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10459-6,Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain,3020498,Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,10459-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,11207-8,Alpha-1-Fetoprotein [Mass/volume] in Body fluid,3034165,Alpha-1-Fetoprotein [Mass/volume] in Body fluid,Measurement,LOINC,Lab Test,S,11207-8,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1833-3,Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid,3027634,Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,1833-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,54348-8,Alpha-1-Fetoprotein [Mass/volume] in Cord blood,40757479,Alpha-1-Fetoprotein [Mass/volume] in Cord blood,Measurement,LOINC,Lab Test,S,54348-8,2008-12-18,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,49761-0,Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid,3032506,Alpha-1-Fetoprotein [Mass/volume] in Peritoneal fluid,Measurement,LOINC,Lab Test,S,49761-0,2007-08-10,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,49762-8,Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid,3033080,Alpha-1-Fetoprotein [Mass/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,49762-8,2007-08-10,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1834-1,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,3009306,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,1834-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83073-7,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay,42529190,Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83073-7,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19173-4,Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid,3024289,Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19173-4,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19177-5,Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma,3021607,Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,19177-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,31993-9,Alpha-1-Fetoprotein [Presence] in Serum or Plasma,3025053,Alpha-1-Fetoprotein [Presence] in Serum or Plasma,Measurement,LOINC,Lab Test,S,31993-9,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,44910-8,Alpha-1-Fetoprotein [Units/volume] in Body fluid,3045958,Alpha-1-Fetoprotein [Units/volume] in Body fluid,Measurement,LOINC,Lab Test,S,44910-8,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,59564-5,Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid,40762626,Alpha-1-Fetoprotein [Units/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,59564-5,2010-04-23,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19172-6,Alpha-1-Fetoprotein [Units/volume] in Pleural fluid,3028331,Alpha-1-Fetoprotein [Units/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19172-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19176-7,Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma,3015916,Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,19176-7,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83072-9,Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay,42529189,Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83072-9,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,41274-2,Alpha-1-Fetoprotein interpretation in Serum or Plasma,3038294,Alpha-1-Fetoprotein interpretation in Serum or Plasma,Measurement,LOINC,Lab Test,S,41274-2,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,49246-2,Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative,3049837,Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative,Measurement,LOINC,Lab Test,S,49246-2,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,49585-3,Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma,3032989,Alpha-1-Fetoprotein multiple of the median cutoff [Multiple of the median] in Serum or Plasma,Measurement,LOINC,Lab Test,S,49585-3,2007-07-16,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,53962-7,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,3039783,Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,53962-7,2008-10-29,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,53960-1,Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma,3039211,Alpha-1-fetoprotein.tumor marker [Moles/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,53960-1,2008-10-29,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,53961-9,Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma,3038911,Alpha-1-fetoprotein.tumor marker [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,53961-9,2008-10-29,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10873-8,Beta-2-Microglobulin [Mass/time] in 24 hour Urine,3022097,Beta-2-Microglobulin [Mass/time] in 24 hour Urine,Measurement,LOINC,Lab Test,S,10873-8,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,54356-1,Beta-2-Microglobulin [Mass/volume] in 24 hour Urine,40757487,Beta-2-Microglobulin [Mass/volume] in 24 hour Urine,Measurement,LOINC,Lab Test,S,54356-1,2008-12-18,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,48166-3,Beta-2-Microglobulin [Mass/volume] in Body fluid,3048467,Beta-2-Microglobulin [Mass/volume] in Body fluid,Measurement,LOINC,Lab Test,S,48166-3,2007-01-16,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1951-3,Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid,3009385,Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,1951-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,49081-3,Beta-2-Microglobulin [Mass/volume] in Dialysis fluid,3049235,Beta-2-Microglobulin [Mass/volume] in Dialysis fluid,Measurement,LOINC,Lab Test,S,49081-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,88711-7,Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid,36304932,Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid,Measurement,LOINC,Lab Test,S,88711-7,2018-06-15,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,59217-0,Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid,40762308,Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid,Measurement,LOINC,Lab Test,S,59217-0,2010-03-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,59218-8,Beta-2-Microglobulin [Mass/volume] in Pleural fluid,40762309,Beta-2-Microglobulin [Mass/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,59218-8,2010-03-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1952-1,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma,3013201,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,1952-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,87708-4,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis,36306084,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis,Measurement,LOINC,Lab Test,S,87708-4,2018-06-15,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83078-6,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay,42529195,Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83078-6,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,1953-9,Beta-2-Microglobulin [Mass/volume] in Urine,3018081,Beta-2-Microglobulin [Mass/volume] in Urine,Measurement,LOINC,Lab Test,S,1953-9,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83077-8,Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay,42529194,Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay,Measurement,LOINC,Lab Test,S,83077-8,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,56662-0,Beta-2-Microglobulin [Moles/time] in 24 hour Urine,40759781,Beta-2-Microglobulin [Moles/time] in 24 hour Urine,Measurement,LOINC,Lab Test,S,56662-0,2009-08-12,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50824-2,Beta-2-Microglobulin [Moles/volume] in 24 hour Urine,3029600,Beta-2-Microglobulin [Moles/volume] in 24 hour Urine,Measurement,LOINC,Lab Test,S,50824-2,2007-10-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,39458-5,Beta-2-Microglobulin [Moles/volume] in Body fluid,3040561,Beta-2-Microglobulin [Moles/volume] in Body fluid,Measurement,LOINC,Lab Test,S,39458-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,32301-4,Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid,3035772,Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,32301-4,2002-07-17,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,14626-6,Beta-2-Microglobulin [Moles/volume] in Serum,3025890,Beta-2-Microglobulin [Moles/volume] in Serum,Measurement,LOINC,Lab Test,S,14626-6,1998-01-16,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,76484-5,Beta-2-Microglobulin [Moles/volume] in Serum or Plasma,46234769,Beta-2-Microglobulin [Moles/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,76484-5,2015-05-08,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,32302-2,Beta-2-Microglobulin [Moles/volume] in Urine,3036303,Beta-2-Microglobulin [Moles/volume] in Urine,Measurement,LOINC,Lab Test,S,32302-2,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,43919-0,Beta-2-Microglobulin [Presence] in Cerebral spinal fluid,3046050,Beta-2-Microglobulin [Presence] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,43919-0,2006-02-20,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,43818-4,Beta-2-Microglobulin [Presence] in Serum,3047079,Beta-2-Microglobulin [Presence] in Serum,Measurement,LOINC,Lab Test,S,43818-4,2006-02-20,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,43819-2,Beta-2-Microglobulin [Presence] in Urine,3043349,Beta-2-Microglobulin [Presence] in Urine,Measurement,LOINC,Lab Test,S,43819-2,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83076-0,Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay,42529193,Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83076-0,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83079-4,Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay,42529196,Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay,Measurement,LOINC,Lab Test,S,83079-4,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10467-9,Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain,3005280,Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,10467-9,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,54355-3,Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum,40757486,Beta-2-Microglobulin in CSF/Beta-2-Microglobulin in serum,Measurement,LOINC,Lab Test,S,54355-3,2008-12-18,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,56786-7,Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum,40759905,Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum,Measurement,LOINC,Lab Test,S,56786-7,2009-08-14,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2006-5,Cancer Ag 125 [Presence] in Serum or Plasma,3007835,Cancer Ag 125 [Presence] in Serum or Plasma,Measurement,LOINC,Lab Test,S,2006-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,48677-9,Cancer Ag 125 [Presence] in Tissue by Immune stain,3050172,Cancer Ag 125 [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,48677-9,2007-03-20,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,11210-2,Cancer Ag 125 [Units/volume] in Body fluid,3002384,Cancer Ag 125 [Units/volume] in Body fluid,Measurement,LOINC,Lab Test,S,11210-2,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,15156-3,Cancer Ag 125 [Units/volume] in Body fluid by Dilution,3002923,Cancer Ag 125 [Units/volume] in Body fluid by Dilution,Measurement,LOINC,Lab Test,S,15156-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50775-6,Cancer Ag 125 [Units/volume] in Cerebral spinal fluid,3032433,Cancer Ag 125 [Units/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,50775-6,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,68923-2,Cancer Ag 125 [Units/volume] in Pericardial fluid,40771464,Cancer Ag 125 [Units/volume] in Pericardial fluid,Measurement,LOINC,Lab Test,S,68923-2,2011-09-29,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,59040-6,Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid,40762133,Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid,Measurement,LOINC,Lab Test,S,59040-6,2010-03-09,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,40618-1,Cancer Ag 125 [Units/volume] in Peritoneal fluid,3039786,Cancer Ag 125 [Units/volume] in Peritoneal fluid,Measurement,LOINC,Lab Test,S,40618-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19165-0,Cancer Ag 125 [Units/volume] in Pleural fluid,3027160,Cancer Ag 125 [Units/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19165-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10334-1,Cancer Ag 125 [Units/volume] in Serum or Plasma,3037551,Cancer Ag 125 [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,10334-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,15157-1,Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution,3002368,Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution,Measurement,LOINC,Lab Test,S,15157-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83082-8,Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay,42529199,Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83082-8,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2007-3,Cancer Ag 15-3 [Presence] in Serum or Plasma,3006742,Cancer Ag 15-3 [Presence] in Serum or Plasma,Measurement,LOINC,Lab Test,S,2007-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,29153-4,Cancer Ag 15-3 [Units/volume] in Body fluid,3027089,Cancer Ag 15-3 [Units/volume] in Body fluid,Measurement,LOINC,Lab Test,S,29153-4,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50776-4,Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid,3029848,Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,50776-4,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50777-2,Cancer Ag 15-3 [Units/volume] in Pericardial fluid,3031930,Cancer Ag 15-3 [Units/volume] in Pericardial fluid,Measurement,LOINC,Lab Test,S,50777-2,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50778-0,Cancer Ag 15-3 [Units/volume] in Peritoneal fluid,3031327,Cancer Ag 15-3 [Units/volume] in Peritoneal fluid,Measurement,LOINC,Lab Test,S,50778-0,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19186-6,Cancer Ag 15-3 [Units/volume] in Pleural fluid,3000337,Cancer Ag 15-3 [Units/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19186-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,6875-9,Cancer Ag 15-3 [Units/volume] in Serum or Plasma,3006588,Cancer Ag 15-3 [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,6875-9,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83083-6,Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay,42529200,Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83083-6,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2009-9,Cancer Ag 19-9 [Presence] in Serum or Plasma,3024552,Cancer Ag 19-9 [Presence] in Serum or Plasma,Measurement,LOINC,Lab Test,S,2009-9,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,26924-1,Cancer Ag 19-9 [Units/volume] in Body fluid,3020472,Cancer Ag 19-9 [Units/volume] in Body fluid,Measurement,LOINC,Lab Test,S,26924-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50779-8,Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid,3029034,Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,50779-8,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50780-6,Cancer Ag 19-9 [Units/volume] in Pericardial fluid,3032748,Cancer Ag 19-9 [Units/volume] in Pericardial fluid,Measurement,LOINC,Lab Test,S,50780-6,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50781-4,Cancer Ag 19-9 [Units/volume] in Peritoneal fluid,3032226,Cancer Ag 19-9 [Units/volume] in Peritoneal fluid,Measurement,LOINC,Lab Test,S,50781-4,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19163-5,Cancer Ag 19-9 [Units/volume] in Pleural fluid,3025483,Cancer Ag 19-9 [Units/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19163-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,24108-3,Cancer Ag 19-9 [Units/volume] in Serum or Plasma,3022914,Cancer Ag 19-9 [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,24108-3,2000-03-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83084-4,Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay,42529201,Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83084-4,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2012-3,Cancer Ag 27-29 [Presence] in Serum or Plasma,3007400,Cancer Ag 27-29 [Presence] in Serum or Plasma,Measurement,LOINC,Lab Test,S,2012-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,50782-2,Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid,3029222,Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,50782-2,2007-10-22,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19187-4,Cancer Ag 27-29 [Units/volume] in Pleural fluid,3003361,Cancer Ag 27-29 [Units/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19187-4,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,17842-6,Cancer Ag 27-29 [Units/volume] in Serum or Plasma,3013520,Cancer Ag 27-29 [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,17842-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,12515-3,Carcinoembryonic Ag [Mass/volume] in Body fluid,3013735,Carcinoembryonic Ag [Mass/volume] in Body fluid,Measurement,LOINC,Lab Test,S,12515-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2037-0,Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid,3023729,Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,2037-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,40621-5,Carcinoembryonic Ag [Mass/volume] in Pericardial fluid,3038258,Carcinoembryonic Ag [Mass/volume] in Pericardial fluid,Measurement,LOINC,Lab Test,S,40621-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,40622-3,Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid,3042038,Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid,Measurement,LOINC,Lab Test,S,40622-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19169-2,Carcinoembryonic Ag [Mass/volume] in Pleural fluid,3009804,Carcinoembryonic Ag [Mass/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19169-2,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2038-8,Carcinoembryonic Ag [Mass/volume] in Semen,3000531,Carcinoembryonic Ag [Mass/volume] in Semen,Measurement,LOINC,Lab Test,S,2038-8,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2039-6,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,3003785,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,2039-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83085-1,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay,42529202,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83085-1,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19170-0,Carcinoembryonic Ag [Moles/volume] in Pleural fluid,3026979,Carcinoembryonic Ag [Moles/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19170-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19167-6,Carcinoembryonic Ag [Moles/volume] in Serum or Plasma,3027665,Carcinoembryonic Ag [Moles/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,19167-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10469-5,Carcinoembryonic Ag [Presence] in Tissue by Immune stain,3003092,Carcinoembryonic Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,10469-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19168-4,Carcinoembryonic Ag [Units/volume] in Pleural fluid,3009274,Carcinoembryonic Ag [Units/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,19168-4,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10560-1,Carcinoembryonic Ag [Units/volume] in Semen,3003143,Carcinoembryonic Ag [Units/volume] in Semen,Measurement,LOINC,Lab Test,S,10560-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19166-8,Carcinoembryonic Ag [Units/volume] in Serum or Plasma,3013444,Carcinoembryonic Ag [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,19166-8,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,85337-4,Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain,36203168,Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain,Measurement,LOINC,Lab Test,S,85337-4,2017-06-23,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,40556-3,Estrogen receptor Ag [Presence] in Tissue by Immune stain,3041343,Estrogen receptor Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,40556-3,2005-04-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,16112-5,Estrogen receptor [Interpretation] in Tissue,3004390,Estrogen receptor [Interpretation] in Tissue,Measurement,LOINC,Lab Test,S,16112-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,14130-9,Estrogen receptor [Moles/mass] in Tissue,3021994,Estrogen receptor [Moles/mass] in Tissue,Measurement,LOINC,Lab Test,S,14130-9,1997-12-18,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,85310-1,Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain,36203146,Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain,Measurement,LOINC,Lab Test,S,85310-1,2017-06-23,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10480-2,Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain,3000481,Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,10480-2,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,48676-1,HER2 [Interpretation] in Tissue,3048223,HER2 [Interpretation] in Tissue,Measurement,LOINC,Lab Test,S,48676-1,2007-03-20,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,32996-1,HER2 [Mass/volume] in Serum,3043105,HER2 [Mass/volume] in Serum,Measurement,LOINC,Lab Test,S,32996-1,2002-10-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,42914-2,HER2 [Mass/volume] in Serum by Immunoassay,3031549,HER2 [Mass/volume] in Serum by Immunoassay,Measurement,LOINC,Lab Test,S,42914-2,2005-11-07,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,85318-4,HER2 [Presence] in Breast cancer specimen by FISH,36203113,HER2 [Presence] in Breast cancer specimen by FISH,Measurement,LOINC,Lab Test,S,85318-4,2017-06-23,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,85319-2,HER2 [Presence] in Breast cancer specimen by Immune stain,36203114,HER2 [Presence] in Breast cancer specimen by Immune stain,Measurement,LOINC,Lab Test,S,85319-2,2017-06-23,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,51981-9,HER2 [Presence] in Serum by Immunoassay,3038499,HER2 [Presence] in Serum by Immunoassay,Measurement,LOINC,Lab Test,S,51981-9,2008-03-14,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,31150-6,HER2 [Presence] in Tissue by FISH,3004053,HER2 [Presence] in Tissue by FISH,Measurement,LOINC,Lab Test,S,31150-6,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,72383-3,HER2 [Presence] in Tissue by Immunoassay,43055014,HER2 [Presence] in Tissue by Immunoassay,Measurement,LOINC,Lab Test,S,72383-3,2012-10-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,72382-5,HER2 [Units/volume] in Tissue by Immunoassay,43055013,HER2 [Units/volume] in Tissue by Immunoassay,Measurement,LOINC,Lab Test,S,72382-5,2012-10-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,18474-7,HER2 Ag [Presence] in Tissue by Immune stain,3019066,HER2 Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,18474-7,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,49683-6,HER2 gene copy number/Chromosome 17 copy number in Tissue by FISH,3032386,HER2 gene copy number/Chromosome 17 copy number in Tissue by FISH,Measurement,LOINC,Lab Test,S,49683-6,2007-08-09,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,74860-8,HER2 gene copy number/nucleus in Tissue by FISH,44816752,HER2 gene copy number/nucleus in Tissue by FISH,Measurement,LOINC,Lab Test,S,74860-8,2014-05-20,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,74885-5,HER2 panel - Tissue by FISH,44816777,HER2 panel - Tissue by FISH,Measurement,LOINC,Lab Test,S,74885-5,2014-05-15,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83054-7,PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative,42529560,PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative,Measurement,LOINC,Lab Test,S,83054-7,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83052-1,PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain,42529558,PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,83052-1,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83056-2,PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative,42529175,PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative,Measurement,LOINC,Lab Test,S,83056-2,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83055-4,PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain,42529561,PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,83055-4,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83057-0,PD-L1 by clone SP142 [Presence] in Tissue by Immune stain,42529176,PD-L1 by clone SP142 [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,83057-0,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83053-9,Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain. (source: LOINC),42529559,Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,83053-9,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,85339-0,Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain,36203170,Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain,Measurement,LOINC,Lab Test,S,85339-0,2017-06-23,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,40557-1,Progesterone receptor Ag [Presence] in Tissue by Immune stain,3041608,Progesterone receptor Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,40557-1,2005-04-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,16113-3,Progesterone receptor [Interpretation] in Tissue,3003289,Progesterone receptor [Interpretation] in Tissue,Measurement,LOINC,Lab Test,S,16113-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10861-3,Progesterone receptor [Mass/mass] in Tissue,3002307,Progesterone receptor [Mass/mass] in Tissue,Measurement,LOINC,Lab Test,S,10861-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,31207-4,Progesterone receptor [Moles/mass] in Tissue,3015210,Progesterone receptor [Moles/mass] in Tissue,Measurement,LOINC,Lab Test,S,31207-4,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,85331-7,Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain,36203162,Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain,Measurement,LOINC,Lab Test,S,85331-7,2017-06-23,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,47738-0,Prostate specific Ag [Mass/volume] in Body fluid,3052038,Prostate specific Ag [Mass/volume] in Body fluid,Measurement,LOINC,Lab Test,S,47738-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,59230-3,Prostate specific Ag [Mass/volume] in Cerebral spinal fluid,40762321,Prostate specific Ag [Mass/volume] in Cerebral spinal fluid,Measurement,LOINC,Lab Test,S,59230-3,2010-03-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,59223-8,Prostate specific Ag [Mass/volume] in Peritoneal fluid,40762314,Prostate specific Ag [Mass/volume] in Peritoneal fluid,Measurement,LOINC,Lab Test,S,59223-8,2010-03-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,59221-2,Prostate specific Ag [Mass/volume] in Pleural fluid,40762312,Prostate specific Ag [Mass/volume] in Pleural fluid,Measurement,LOINC,Lab Test,S,59221-2,2010-03-25,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19199-9,Prostate specific Ag [Mass/volume] in Semen,3038011,Prostate specific Ag [Mass/volume] in Semen,Measurement,LOINC,Lab Test,S,19199-9,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,2857-1,Prostate specific Ag [Mass/volume] in Serum or Plasma,3013603,Prostate specific Ag [Mass/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,2857-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,35741-8,Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL,3034548,Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL,Measurement,LOINC,Lab Test,S,35741-8,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,83112-3,Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay,42529229,Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay,Measurement,LOINC,Lab Test,S,83112-3,2017-02-21,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,34611-4,Prostate specific Ag [Mass/volume] in Urine,3032915,Prostate specific Ag [Mass/volume] in Urine,Measurement,LOINC,Lab Test,S,34611-4,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19200-5,Prostate specific Ag [Moles/volume] in Semen,3002178,Prostate specific Ag [Moles/volume] in Semen,Measurement,LOINC,Lab Test,S,19200-5,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19197-3,Prostate specific Ag [Moles/volume] in Serum or Plasma,3037249,Prostate specific Ag [Moles/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,19197-3,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,10508-0,Prostate specific Ag [Presence] in Tissue by Immune stain,3007273,Prostate specific Ag [Presence] in Tissue by Immune stain,Measurement,LOINC,Lab Test,S,10508-0,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19198-1,Prostate specific Ag [Units/volume] in Semen,3037774,Prostate specific Ag [Units/volume] in Semen,Measurement,LOINC,Lab Test,S,19198-1,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,19195-7,Prostate specific Ag [Units/volume] in Serum or Plasma,3002131,Prostate specific Ag [Units/volume] in Serum or Plasma,Measurement,LOINC,Lab Test,S,19195-7,1970-01-01,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,15325-4,Prostate specific Ag/Prostate volume calculated,3021841,Prostate specific Ag/Prostate volume calculated,Measurement,LOINC,Clinical Observation,S,15325-4,1998-03-19,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,15323-9,"Prostate specific Ag/Prostate volume calculated from height, width and length",3038091,"Prostate specific Ag/Prostate volume calculated from height, width and length",Measurement,LOINC,Clinical Observation,S,15323-9,1998-03-19,2099-12-31,NA
TumorMarkerTestVS,LOINC,NA,15324-7,Prostate specific Ag/Prostate volume calculated from planimetry,3033468,Prostate specific Ag/Prostate volume calculated from planimetry,Measurement,LOINC,Clinical Observation,S,15324-7,1998-03-19,2099-12-31,NA
